Atypical clinical features of post COVID-19 mucormycosis: A case series
- PMID: 37127941
- PMCID: PMC10441602
- DOI: 10.1002/cre2.743
Atypical clinical features of post COVID-19 mucormycosis: A case series
Abstract
Objectives: This case series aims to evaluate patients affected with post COVID-19 mucormycosis from clinical presentation to surgical and pharmacological treatment to improve the disease prognosis.
Material and methods: This case series was conducted at a specialized surgery hospital in Baghdad Medical City for over 10 months. Fifteen cases who had mild to severe COVID-19 infections followed by symptoms similar to aggressive periodontitis, such as mobility and bone resorption around the multiple maxillary teeth, were included in this case series.
Results: All patients did not receive COVID-19 vaccination; seven had a history of diabetes mellitus type 2, another five patients had a history of diabetes-like syndrome during the COVID-19 infection, and the remaining three patients had no history of any systemic diseases. No intracranial involvement was seen in all patients, and bilateral sinus involvement was seen in three patients.
Conclusion: Being highly suspicious of all patients affected with COVID-19 is highly recommended to avoid the complications of the late diagnosis of mucormycosis. In addition, our knowledge and methods in diagnosing and treating classical mucormycosis should be modified regarding post COVID-19 mucormycosis.
Keywords: COVID-19; diabetes mellitus; mucormycosis.
© 2023 The Authors. Clinical and Experimental Dental Research published by John Wiley & Sons Ltd.
Conflict of interest statement
The authors declare no conflict of interest.
Figures




Similar articles
-
Maxillary mucormycosis and aspergillosis in post-COVID-19 patients in Mexico: A case series.J Stomatol Oral Maxillofac Surg. 2024 Feb;125(1):101615. doi: 10.1016/j.jormas.2023.101615. Epub 2023 Aug 28. J Stomatol Oral Maxillofac Surg. 2024. PMID: 37648209
-
[COVID-19 associated sino-orbital mucormycosis].Vestn Otorinolaringol. 2023;88(2):31-37. doi: 10.17116/otorino20228802131. Vestn Otorinolaringol. 2023. PMID: 37184552 Russian.
-
Rhino-orbital mucormycosis: Our experiences with clinical features and management in a tertiary care center.Rom J Ophthalmol. 2021 Oct-Dec;65(4):339-353. doi: 10.22336/rjo.2021.69. Rom J Ophthalmol. 2021. PMID: 35087975 Free PMC article.
-
Post COVID-19 rhinocerebral mucormycosis: a case report and literature review.Pan Afr Med J. 2022 Jul 14;42:202. doi: 10.11604/pamj.2022.42.202.33690. eCollection 2022. Pan Afr Med J. 2022. PMID: 36284570 Free PMC article. Review.
-
COVID-19-Associated Mucormycosis: An Opportunistic Fungal Infection. A Case Series and Review.Int J Infect Dis. 2022 Aug;121:203-210. doi: 10.1016/j.ijid.2022.05.005. Epub 2022 May 6. Int J Infect Dis. 2022. PMID: 35533833 Free PMC article. Review.
Cited by
-
Fungal infections in patients after recovering from COVID-19: a systematic review.Ther Adv Infect Dis. 2024 May 4;11:20499361241242963. doi: 10.1177/20499361241242963. eCollection 2024 Jan-Dec. Ther Adv Infect Dis. 2024. PMID: 38706456 Free PMC article. Review.
References
-
- Almas, T. , Nazar, W. , Khedro, T. , Kanawati, M. A. , Adnan, A. , Almuhaileej, M. , Alshamlan, A. , Abdulhadi, A. , Manamperi, K. T. , & Sarfraz, S. (2021). COVID‐19 and mucormycosis superinfection: Exploring the missing pathophysiological links. Annals of Medicine and Surgery, 1(68), 102655. - PMC - PubMed
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical